The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 14, 2020
Filed:
Jan. 12, 2017
Applicant:
Hadasit Medical Research Services and Development Ltd., Jerusalem, IL;
Inventors:
Eyal Yosef Mishani, Mevasseret Zion, IL;
Ofer Shamni, Jerusalem, IL;
Galith Rachel Abourbeh-Gofrit, Jerusalem, IL;
Assignee:
Hadasit Medical Research Services and Development Ltd., Jerusalem, IL;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 51/00 (2006.01); A61M 36/14 (2006.01); C07D 239/94 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61K 51/04 (2006.01); C07B 59/00 (2006.01); C12Q 1/6886 (2018.01);
U.S. Cl.
CPC ...
C07D 239/94 (2013.01); A61K 45/06 (2013.01); A61K 51/0459 (2013.01); A61P 35/00 (2018.01); C07B 59/002 (2013.01); C12Q 1/6886 (2013.01); C07B 2200/05 (2013.01); C12Q 2600/106 (2013.01);
Abstract
Radiolabeled compounds which are erlotinib analogs that feature a radioactive halogen and processes of preparing same are disclosed. Uses of these radiolabeled compounds in radioimaging, for identifying and monitoring a level, distribution and/or mutational status of deregulated EGFR, and/or in radiotherapy, are also disclosed.
Mishani, Eyal. (2020). Radiolabeled erlotinib analogs and uses thereof (U.S. Patent No. 10710968). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10710968
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile